| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 13.83M | $ 14.78M | $ 2.41M | $ 13.18M | $ 6.00M |
| Gross Profit | $ -11.31K | $ -281.53K | $ 122.13K | $ 1.27M | $ 605.13K |
| Operating Income | $ -4.00M | $ -166.30M | $ -8.64M | $ -14.27M | $ -3.26M |
| EBITDA | $ -1.63M | $ -1.77M | $ -8.64M | $ -14.27M | $ -3.19M |
| Net Income | $ -18.67M | $ -134.98M | $ -9.46M | $ -1.36M | $ -16.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 170.57K | $ 176.23M | $ 85.17M | $ 7.92M | $ 18.43M |
| Total Assets | $ 189.63M | $ 214.95M | $ 142.02M | $ 20.46M | $ 62.81M |
| Total Debt | $ 375.66K | $ 81.74K | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 205.09K | $ -176.15M | $ -85.17M | $ -7.92M | $ -18.43M |
| Total Liabilities | $ 8.71M | $ 15.80M | $ 3.59M | $ 11.62M | $ 50.52M |
| Stockholders' Equity | $ 180.93M | $ 199.12M | $ 138.37M | $ 8.73M | $ 12.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -188.46M | $ 1.02M | $ 1.35M | $ -3.25M | $ -8.63M |
| Operating Cash Flow | $ -12.79M | $ 1.18M | $ 1.35M | $ -3.25M | $ -8.63M |
| Investing Cash Flow | $ -163.46M | $ -105.91M | $ -54.72M | $ 18.47M | $ -19.96M |
| Financing Cash Flow | $ 350.00K | $ 195.88M | $ 131.65M | $ -27.51M | $ 34.78M |
Akso Health Group Sponsored ADR Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.